Indian-American doctor pleads guilty to healthcare fraud in US

By Lalit K Jha Washington, Sep 20 : An Indian-American lady doctor has pleaded guilty to a healthcare fraud in the US, the Justice Department has said.

Dr Jayam Krishna Iyer from Florida faces a maximum penalty of 10 years in federal prison, or 20 years, if her offence involves serious bodily injury.

As part of the plea on Tuesday, the 66-year-old doctor has agreed to surrender both her Drug Enforcement Administration (DEA) registration number that she used to prescribe controlled substances and her Florida medical licence, and to a permanent exclusion from the Medicare and Medicaid programmes, the department said in a press release.

Iyer owned and operated Creative Medical Centre, a pain management clinic located at Druid Road East in Florida’s Clearwater area.

She billed Medicare and Medicaid for office visits, tests and services provided to patients using her National Provider Identification (NPI) number, and wrote prescriptions for controlled substances, the release said.

Between July 2011 and December 2017, Iyer executed and carried out a scheme to defraud Medicare by billing for face-to-face office visits with Medicare beneficiaries, when, in fact, certain patients did not go to her office and were not examined by her on the claimed dates.

Instead, family members of the patients went to Iyer’s office with notes requesting her to issue and provide prescriptions, including for controlled substances like oxycodone, a pain killer.

Iyer used to issue those prescriptions, thereby violating a Florida law that required doctors to perform an in-person office visit and examination of each patient before issuing controlled substance prescriptions.

She also falsified her electronic medical records, including vital statistics, to make it appear that the patient was present in her office.

Iyer submitted at least USD 51,500 in these types of false and fraudulent Medicare claims, the release said. LKJ SCY SCY SCY

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise